Effects of dupilumab on hair in patients with atopic dermatitis - a review of the literature
Dupilumab is a recombinant human monoclonal antibody of the IgG4 class. Its mechanism of action can most broadly be described as inhibition of interleukin 4 and 13-mediated signal transduction. These cytokines are the main drivers of inflammatory diseases such as atopic dermatitis (AD) and asthma....
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2022-11-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/39918 |